Prostaglandin F2α receptor (FP) is the primary therapeutic target for glaucoma and several other diseases. Here, the authors reveal structural mechanisms of ligand recognition, receptor activation, and G protein coupling by FP.
- Canrong Wu
- Youwei Xu
- H. Eric Xu